Literature DB >> 35925138

[The importance of microbiological results for the treatment of complicated appendicitis-a monocentric case-control study].

F-X Anzinger1, K Rothe2, S Reischl3, C Stöss1, A Novotny1, D Wilhelm1, H Friess1, P-A Neumann4.   

Abstract

BACKGROUND: Patients with complicated appendicitis frequently develop postoperative septic complications. There are no uniform standards for the choice of perioperative antibiotic prophylaxis and the duration of postoperative antibiotic treatment. The purpose of this study was to investigate associations between microbiological samples and postoperative complications.
METHODS: Patients with appendectomy and positive intraoperative swabs during 2013-2018 were included in this case-control study. Pathogen classes and their resistance patterns were evaluated in initial and follow-up swabs and compared in each of the groups with and without complications.
RESULTS: A total of 870 patients underwent surgery during the period studied. Pathogen detection succeeded in 102 of 210 cases (48.6%) with suspected bacterial peritoneal contamination. Conversion from laparoscopic to open intra-abdominal perforation and the presence of an abscess were independent risk factors for wound infections in the multivariate analysis. The combination of different classes of pathogens resulted in significantly increased overall resistance to ampicillin/sulbactam in both the initial swabs (57%) and the follow-up swabs (73%). Resistant E. coli strains combined with certain anaerobes were also regularly detected in postoperative intra-abdominal abscesses. Piperacillin/tazobactam was effective against 83% of positive swabs in our resistance tests.
CONCLUSION: Surgical treatment for complicated appendicitis remains the central therapeutic column. A regular review of the existing resistance patterns in perforated appendicitis can help to adjust and improve antibiotic treatment. Piperacillin/tazobactam should be used cautiously as a reserve antibiotic. A valid alternative is second or third generation cephalosporins in combination with metronidazole.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Abdominal abscess; Acute complicated appendicitis; Intraoperative swab; Perforated appendicitis; Postoperative antibiotics

Year:  2022        PMID: 35925138     DOI: 10.1007/s00104-022-01655-2

Source DB:  PubMed          Journal:  Chirurgie (Heidelb)        ISSN: 2731-6971


  19 in total

1.  Retrospective Multicenter Study on Risk Factors for Surgical Site Infections after Appendectomy for Acute Appendicitis.

Authors:  Louis J X Giesen; Anne Loes van den Boom; Charles C van Rossem; P T den Hoed; Bas P L Wijnhoven
Journal:  Dig Surg       Date:  2016-09-16       Impact factor: 2.588

2.  Risk factors for morbidity after appendectomy.

Authors:  Anne Andert; H P Alizai; C D Klink; N Neitzke; C Fitzner; C Heidenhain; A Kroh; U P Neumann; M Binnebösel
Journal:  Langenbecks Arch Surg       Date:  2017-07-27       Impact factor: 3.445

Review 3.  Acute appendicitis: modern understanding of pathogenesis, diagnosis, and management.

Authors:  Aneel Bhangu; Kjetil Søreide; Salomone Di Saverio; Jeanette Hansson Assarsson; Frederick Thurston Drake
Journal:  Lancet       Date:  2015-09-26       Impact factor: 79.321

4.  Impact of co-amoxicillin-resistant Escherichia coli and Pseudomonas aeruginosa on the rate of infectious complications in paediatric complicated appendicitis.

Authors:  Véronique Andrey; Pierre-Alex Crisinel; Guy Prod'hom; Antony Croxatto; Jean-Marc Joseph
Journal:  Swiss Med Wkly       Date:  2019-04-26       Impact factor: 2.193

5.  Pus Samples in Complicated Appendicitis: An Important Investigation or a Waste of Resources: A Prospective Cohort Study.

Authors:  A A Akingboye; B Davies; T Tien
Journal:  Scand J Surg       Date:  2018-07-04       Impact factor: 2.360

Review 6.  Diagnosis and treatment of acute appendicitis: 2020 update of the WSES Jerusalem guidelines.

Authors:  Salomone Di Saverio; Mauro Podda; Belinda De Simone; Marco Ceresoli; Goran Augustin; Alice Gori; Marja Boermeester; Massimo Sartelli; Federico Coccolini; Antonio Tarasconi; Nicola De' Angelis; Dieter G Weber; Matti Tolonen; Arianna Birindelli; Walter Biffl; Ernest E Moore; Michael Kelly; Kjetil Soreide; Jeffry Kashuk; Richard Ten Broek; Carlos Augusto Gomes; Michael Sugrue; Richard Justin Davies; Dimitrios Damaskos; Ari Leppäniemi; Andrew Kirkpatrick; Andrew B Peitzman; Gustavo P Fraga; Ronald V Maier; Raul Coimbra; Massimo Chiarugi; Gabriele Sganga; Adolfo Pisanu; Gian Luigi De' Angelis; Edward Tan; Harry Van Goor; Francesco Pata; Isidoro Di Carlo; Osvaldo Chiara; Andrey Litvin; Fabio C Campanile; Boris Sakakushev; Gia Tomadze; Zaza Demetrashvili; Rifat Latifi; Fakri Abu-Zidan; Oreste Romeo; Helmut Segovia-Lohse; Gianluca Baiocchi; David Costa; Sandro Rizoli; Zsolt J Balogh; Cino Bendinelli; Thomas Scalea; Rao Ivatury; George Velmahos; Roland Andersson; Yoram Kluger; Luca Ansaloni; Fausto Catena
Journal:  World J Emerg Surg       Date:  2020-04-15       Impact factor: 5.469

7.  Risk factors for adverse outcomes after the surgical treatment of appendicitis in adults.

Authors:  Julie A Margenthaler; Walter E Longo; Katherine S Virgo; Frank E Johnson; Charles A Oprian; William G Henderson; Jennifer Daley; Shukri F Khuri
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

8.  Acute appendicitis in the developing world is a morbid disease.

Authors:  V Y Kong; B Sartorius; D L Clarke
Journal:  Ann R Coll Surg Engl       Date:  2015-07       Impact factor: 1.891

9.  Disease burden of appendectomy for appendicitis: a population-based cohort study.

Authors:  Elisabeth M L de Wijkerslooth; Anne Loes van den Boom; Bas P L Wijnhoven
Journal:  Surg Endosc       Date:  2019-03-27       Impact factor: 4.584

10.  Variation in Classification and Postoperative Management of Complex Appendicitis: A European Survey.

Authors:  Elisabeth M L de Wijkerslooth; Anne Loes van den Boom; Bas P L Wijnhoven
Journal:  World J Surg       Date:  2019-02       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.